Evidence map›Paper›PMID 41078390›Full record

ArticleFrontiers in chemistry2025

Hardtank

Radosław Kowalski, Kamil Belniak, Grażyna Kowalska, Marzena Włodarczyk-Stasiak, Artur Mazurek, Tomasz Baj

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Low-Processed Extracts from Peppermint Leaves (Molecules (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Radosław KowalskiDepartment of Analysis and Evaluation of Food Quality, University of Life Sciences in Lublin, Lublin, Poland.
Kamil BelniakDepartment of Analysis and Evaluation of Food Quality, University of Life Sciences in Lublin, Lublin, Poland.
Grażyna KowalskaDepartment of Tourism and Recreation, University of Life Sciences in Lublin, Lublin, Poland.
Marzena Włodarczyk-StasiakDepartment of Analysis and Evaluation of Food Quality, University of Life Sciences in Lublin, Lublin, Poland.
Artur MazurekDepartment of Analysis and Evaluation of Food Quality, University of Life Sciences in Lublin, Lublin, Poland.
Tomasz BajDepartment of Pharmacognosy with Medicinal Plants Garden, Medical University of Lublin, Lublin, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hardtank® is a pressure-modulated, solvent-free cold extraction that shortens brewing while maximizing bioactive recovery from roasted coffee. Methods: We produced a Nitro Cold Brew beverage from roasted Yellow Bourbon beans using Hardtank® (550 g : 10,000 mL water, 30 min, 0.3-1.5 bar) and compared its composition and antioxidant activity with laboratory extracts from roasted and green beans obtained by hot water infusion (93 °C, 5 min) and by methanol extraction (70% reflux, 2 h; 100% reflux, 2 h; 70% shake, 5 min). We measured caffeine, chlorogenic acid (and derivatives), total phenolics, total flavonoids, and antioxidant activity by the ferric reducing antioxidant power and DPPH radical tests, expressed as Trolox equivalents. Results and discussion: Nitro Cold Brew contained 375.8±2.4 mg phenolics + flavonoids per 100 mL, 72.4±1.1 mg caffeine per 100 mL, and 78.2±2.3 mg chlorogenic acid per 100 mL, with ferric reducing antioxidant power 27.9±0.5 mM and DPPH 11.7±0.6 mM. Using 70% methanol reflux as the 100% reference, Hardtank® achieved 135.3% for phenolics + flavonoids, 119.7% for caffeine, and up to 172.3% for chlorogenic acid. Overall, Hardtank® yielded a ready-to-drink coffee with bioactive and antioxidant profiles comparable to or better than laboratory reflux extracts, while operating rapidly and without organic solvents, indicating promise for scalable production of functional coffee beverages.

Indexed as

antioxidant activitycaffeinechlorogenic acidcold brew coffeehardtank®phenolic compounds

Identifiers

PMID41078390
PMCPMC12511873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.